Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 2:19 PM EDT

Bio-Techne (TECH) Net Margin (2009 - 2026)

Bio-Techne (TECH) posted quarterly Net Margin of 16.39% for Q1 2026, up 925.0% year-over-year from 1.6% in Q1 2025, and up 27.6% quarter-over-quarter from 12.85% in Q4 2025.

Analysis

Bio-Techne (TECH) Net Margin (2009 - 2026) Analysis & Trends

Bio-Techne's Net Margin history runs 18 years deep, the most recent figure standing at 16.39% for Q1 2026.

  • In Q1 2026, Net Margin rose 925.0% year-over-year to 16.39%; the TTM figure through Mar 2026 stood at 1.88% (down 479.0% YoY), while the FY2025 annual figure was 1.1%, down 1120.0% from the prior year.
  • Net Margin for Q1 2026 stood at 16.39%, up from 12.85% in the prior quarter.
  • The five-year high for Net Margin was 4486.7% in Q3 2022, with the low at 32.97% in Q2 2025.
  • The 5-year median for Net Margin is 16.17% (2024), against an average of 275.3%.
  • The sharpest annual moves came in 2022 and 2023: Net Margin surged 445993 bps in 2022, then tumbled 446829 bps in 2023.
  • Bio-Techne's Net Margin stood at 18.41% in 2022, then plunged by 45 bps to 10.08% in 2023, then grew by 17 bps to 11.75% in 2024, then rose by 9 bps to 12.85% in 2025, then gained by 28 bps to 16.39% in 2026.
  • Business Quant data shows TECH's Net Margin at 16.39% in Q1 2026, 12.85% in Q4 2025, and 13.33% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 30.23%
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn 31.16%
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn -539.31%
5 Revolution Medicines 44.08 Bn 44.08 Bn - -
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 13.90%
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 12.74%
8 Royalty Pharma 28.42 Bn 27.59 Bn - 12.09%
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -3.12%
10 Bio-Techne 11.30 Bn 11.03 Bn 211.39 Mn 17.01%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.01%
Mar 31, 2026 16.39%
Dec 31, 2025 12.85%
Sep 30, 2025 13.33%
Jun 30, 2025 -21.72%
Mar 31, 2025 7.14%
Dec 31, 2024 11.75%
Sep 30, 2024 11.61%
Jun 30, 2024 0.14%
Mar 31, 2024 16.17%
Dec 31, 2023 10.08%
Sep 30, 2023 18.41%
Jun 30, 2023 15.16%
Mar 31, 2023 23.87%
Dec 31, 2022 18.41%
Sep 30, 2022 33.28%
Jun 30, 2022 21.48%
Mar 31, 2022 20.71%
Dec 31, 2021 26.76%
Sep 30, 2021 26.77%